Related Experiment Videos
Antigen-specific therapy of experimental metastases
Cancer
|March 15, 1985
Summary
Surgical removal of methylcholanthrene-induced tumors (MCA-F) in mice can enhance lung metastasis. Early tumor resection (7-14 days) leads to more lung colonies than later resection (28 days), indicating immune status impacts metastasis.
Area of Science:
- Oncology
- Immunology
- Cancer Metastasis
Background:
- Surgical resection is a primary cancer treatment.
- Tumor burden and host immune status can influence cancer progression and metastasis.
- Understanding the interplay between surgery, immunity, and metastasis is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the impact of curative tumor resection timing on experimentally induced lung metastasis in a mouse model.
- To evaluate the efficacy of tumor-specific transplantation antigen (CBE) and cyclophosphamide (CY) in preventing postoperative lung metastasis.
- To assess the effect of CBE on immune cell populations and its potential in combination therapy.
Main Methods:
- Methylcholanthrene-induced tumor (MCA-F) model in C3H/HeJ mice.
- Intravenous injection of a highly metastatic cell variant (clone 9-4) post-tumor resection.
- Assessment of lung colony counts at different time points after tumor inoculation and resection (7, 14, and 28 days).
- Administration of tumor-specific transplantation antigen (CBE) and cyclophosphamide (CY).
- Analysis of spleen helper-suppressor cell ratios.
Main Results:
- Curative resection of progressive tumors promoted artificial lung metastases.
- Mice resected 7 or 14 days post-inoculation showed significantly more lung metastases compared to those resected at 28 days.
- Neither CBE nor CY alone prevented lung colonization.
- CBE administration decreased the helper-suppressor ratio in mice with 14-day resected tumors.
- Combined therapy with CBE and an antisuppressor agent reduced metastases irrespective of tumor size.
Conclusions:
- The timing of tumor resection significantly influences postoperative lung metastasis, likely due to changes in host immune status.
- Single-agent therapies (CBE or CY) were insufficient to prevent lung colonization.
- Combined immunotherapy targeting tumor antigen and suppressor cells shows promise in reducing metastasis after tumor resection.